AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Septerna, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG014WY1VC7
40.41▼ 0.47 (-1.15%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
40.88
Day's Range
39.65 – 41.21
52-Week Range
17.55 – 51.10
Volume
200.3K
Avg Volume
381.2K
Share Statistics
Shares Outstanding
Employees
130
Exchange
XNAS
Listed
2024-10-25
Share count as of August 5, 2026

Septerna, Inc. Common Stock (SEPN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Septerna, Inc. Common Stock (SEPN)
What is Septerna, Inc. Common Stock's Market Cap?
Septerna, Inc. Common Stock's Market Cap is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's Enterprise Value?
Septerna, Inc. Common Stock's Enterprise Value is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's Price / Sales?
Septerna, Inc. Common Stock's Price / Sales is 19.1×, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's EV / Revenue?
Septerna, Inc. Common Stock's EV / Revenue is 15.3×, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's EV / EBITDA?
Septerna, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's Revenue (TTM)?
Septerna, Inc. Common Stock's Revenue (TTM) is $98.9M, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's Net Income (TTM)?
Septerna, Inc. Common Stock's Net Income (TTM) is -$24.2M, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's EBITDA?
Septerna, Inc. Common Stock's EBITDA is -$41.9M, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's Diluted EPS (TTM)?
Septerna, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.
What is Septerna, Inc. Common Stock's EBITDA Margin?
Septerna, Inc. Common Stock's EBITDA Margin is -42.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SEPNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
Revenue
YoY growth+22375.6%+12011.0%+11276.4%+12113.1%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue162.9%150.1%166.4%87.8%
Loss from operations
% of revenue-62.9%-50.1%-66.4%12.2%
Other income, net:
Interest income
Other expense, net
Total other income, net
Loss before provision for income taxes
Provision for income taxes
Net loss
% of revenue-48.7%-32.6%-44.5%38.0%
Net loss per share, basic
Net loss per share, diluted